Clinical trial
Inflammation and Metabolism After Radiotherapy- Predictors of Survival in Patients With Head and Neck Cancer
NCT03343236 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammation and Metabolism After Radiotherapy- Predictors of Survival in Patients With Head and Neck Cancer
- Lead sponsor
- Uppsala University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 1, 2015
- Completion date
- December 31, 2027
- Enrollment
- 522 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck neoplasms, inflammation, metabolism, radiotherapy side effect